Home > Healthcare & Medical Devices > Aquaculture Healthcare Market

Aquaculture Healthcare Market Size By Product (Drug {Parasiticides, Anti-inflammatory, Anti-infectives}, Vaccines {Modified Live Vaccines (MLV), Killed Inactivated Vaccines}, Medicated Feed Additives {Antibiotics, Vitamins, Amino Acids, Enzymes, Antioxidants, Prebiotics and Probiotics, Minerals, Hormones}), By Species (Fish {Freshwater Species [Tilapia, Carp], Marine Species [Sea Bass, Sea Bream, Turbot], Diadromous Species [Salmon, Trout]}, Crustaceans {Prawns, Shrimps}), By Infections (Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections) By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Distributors, Online Stores, Retail/Aqua Stores), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI4536
  • Published Date: Dec 2022
  • Report Format: PDF

Industry Statistics

Aquaculture Healthcare Market size was valued at over USD 900 million in 2022 and is set to depict more than 8.5% CAGR over 2023-2032 driven by the burgeoning demand for fish protein across the globe.
 

Population growth is resulting in a greater demand for quality nutrition and an upsurge in fish consumption is a major factor accelerating the industry development. A growing number of people are relying on aquaculture to offer a sustainable supply of fish since natural fish sources cannot support this rate of fishing. In addition, the demand for healthcare solutions is likely to be bolstered by the increasing number of aquaculture farms.
 

Get more details on this report - Request Free Sample PDF
 

Lack of knowledge about diseases in aquatic animals may limit revenue growth

Market development is expected to be hampered by a lack of knowledge about epidemiology and illness treatment for aquatic animals in the short term. Aquaculture has always trailed behind other livestock; hence, there is a lack of research on aquaculture health, resulting in fewer healthcare options, which may further limit product uptake. However, growing initiatives by industry participants and retail aqua stores to raise awareness among fish farmers about the various benefits associated with aquaculture healthcare solutions, as well as the mounting availability of novel solutions, may help them overcome this constraint through the projected period.
 

Growing use to lower infection risks in aquatic creatures to spur medicated feed additives demand

In terms of product, the aquaculture healthcare market share from the medicated feed additives segment is foreseen to record significant growth at over 10% CAGR through 2032. The segment is further classified into topical treatments, amino acids, antioxidants, enzymes, antibiotics, minerals, hormones, prebiotics and probiotics, and vitamins. Medicated feed additives include medications or antibiotics that assist aquaculture farmers in lowering the risks of illnesses, infections, or diseases in aquatic creatures as well as in increasing the nutritional value and quality of food, which is expected to positively influence their uptake through 2032.
 

Get more details on this report - Request Free Sample PDF
 

Rising demand for high-quality fish proteins to propel the fish segment demand

On the basis of species, the fish segment of the aquaculture healthcare market accounted for over USD 775 million in revenue in 2022, the report claims. The need for aquaculture healthcare solutions has increased due to the rising demand for high-quality fish proteins, which is slated to boost segment development. The flourishing fish farming sector, which requires better fish productivity, is projected to be a significant driver impelling the business growth through 2032.
 

High vulnerability of aquatic species to parasites to supplement industry expansion

Get more details on this report - Request Free Sample PDF
 

Aquaculture healthcare market is bifurcated by infection into bacterial infection, viral infection, parasitic infection, and fungal infection. The parasitic infection segment is foreseen to surpass USD 450 million by 2032. The increased vulnerability of aquatic species to parasites, such as sea lice and sea fleas has resulted in an upsurge in the demand for parasitic infection medications. For instance, salmon are highly vulnerable to sea lice infection. Furthermore, the development of novel treatments and innovative solutions to treat these infections is expected to stimulate segment trends.
 

Capability of lowering handling stress for fish to increase topical therapeutics adoption

As per the route of administration, the aquaculture healthcare market is segregated based on oral, topical, and injectable. The topical segment is anticipated to register more than USD 735 million by 2032, the study cites. Topical therapeutics lower the handling stress for fish and improve the outcomes, making them a highly popular alternative solution among fish farmers. Additionally, smaller fish and fry require topical immunizations before they can be vaccinated, boosting the demand for topical treatments, which is speculated to support segment expansion through 2032.
 

Access to varied therapeutic solutions to amplify retail stores segment revenues

The aquaculture healthcare market is segmented based on distribution channels into retail/aqua stores, distributors, online stores, and others. The retail/aqua stores segment is estimated to generate more than USD 460 million in revenue by 2032 owing to the access to numerous therapeutic solutions at retail stores. The increasing availability of specialty products stocked for aquatic animals at aqua stores is estimated to fuel segment expansion.
 

Rising awareness of aquaculture healthcare solutions to favor the APAC industry value

Get more details on this report - Request Free Sample PDF
 

Asia Pacific aquaculture healthcare market is poised to grow at more than 9.5% CAGR through the forecast timeline. Several APAC nations, including Thailand, India, China, and Indonesia, are among the world's largest producers of crustaceans, resulting in growing regional demand for crustacean therapeutic products. Furthermore, surging awareness among fish farmers about the significance of aquaculture healthcare is likely to contribute to increased product adoption, thereby propelling regional market outlook.
 

Strategic acquisitions to define the industry landscape

Enterprises involved in the aquaculture healthcare market include Virbac, Zeal Aqua, Phibro Animal Health Corporation, Benchmark PLC, Ceva Sante, Archer Daniels Midland Company, Elanco, Merck, and Zoetis LLC, among others. These companies are focused on reaching untapped markets to increase sales. For instance, in September 2020, Virbac, an animal health pharmaceutical firm, acquired a variety of tilapia vaccines from Ictyogroup, an animal health company specializing in R&D biology, and also signed a deal with Ictyogroup for the development of additional tilapia vaccines for the Aqua Virbac division.
 

Impact of COVID-19 on aquaculture healthcare market trends

The COVID-19 outbreak negatively impacted virtually all enterprises and caused economic activities to cease. The aquaculture and fishing sectors have been overlooked or disregarded while discussing measures to combat the grave conditions of the COVID-19 pandemic. The aquaculture healthcare industry's revenue was thus hampered during the pandemic owing to the low demand for aquaculture animals, resulting in a declining requirement for treatments for aquatic animals. However, in the post-pandemic scenario, the market is expanding due to the rising need for nutrient-dense food products, which is projected to supplement the business growth.
 

The aquaculture healthcare market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

By Product

  • Drugs
    • Parasiticides
    • Anti-inflammatory
    • Anti-infectives
    • Others
  • Vaccines
    • Modified live vaccines
    • Killed inactivated vaccines
    • Others
  • Medicated Feed Additives
    • Amino Acids
    • Antibiotics
    • Antioxidants
    • Enzymes
    • Hormones
    • Minerals
    • Prebiotics and Probiotics
    • Vitamins
    • Others

By Species

  • Fishes
    • Freshwater
      • Tilapia
      • Carp
      • Others
    • Marine species
      • Seabass
      • Seabream
      • Turbot
      • Others
    • Diadromous species
      • Salmon
      • Trout
      • Others
  • Crustaceans
    • Prawns
    • Shrimps
    • Others
  • Others

By Infection

  • Bacterial Infection
  • Viral Infection
  • Parasitic Infection
  • Fungal Infection

By Route of Administration

  • Oral
  • Injectable
  • Topical

By Distribution Channel

  • Distributors
  • Online stores
  • Retail/Aqua stores
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Denmark
    • Iceland
    • Ireland
    • Norway
    • Poland
    • Turkey
  • Asia Pacific
    • China
    • Vietnam
    • Indonesia
    • India
    • Thailand
    • Bangladesh
    • Philippines
    • Australia
    • New Zealand
  • Latin America
    • Brazil
    • Mexico
    • Chile
  • Middle East & Africa
    • Iran
    • Egypt

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for aquaculture healthcare was valued at more than USD 900 million in 2022 and is poised to grow at over 8.5% CAGR through 2032 owing to the burgeoning demand for fish protein worldwide.
Retail/aqua stores segment is anticipated to generate USD 460 million in revenue by 2032 due to the increasing availability of innovative therapeutic treatments at retail stores.
Asia Pacific aquaculture healthcare market is expected to expand at more than 9.5% CAGR over the projected period owing to the rising demand for crustacean therapeutic goods throughout the region.
Leading industry participants involved in the aquaculture healthcare industry are Virbac, Zeal Aqua, Phibro Animal Health Corporation, Benchmark PLC, Ceva Sante, Archer Daniels Midland Company, Elanco, Merck, Zoetis LLC, and others

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 921
  • Countries covered: 27
  • Pages: 420
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount